melanoma-overexpressed antigen 1
Melanoma-overexpressed antigen 1 (24-37) is a synthetic peptide fragment derived from the melanoma-associated antigen MELOE-1, corresponding to amino acid residues 24 through 37 of the parent protein. As a peptide epitope, it plays a significant role in immunological and oncological research, particularly in the context of antigen processing, T-cell recognition, and tumor-associated antigen studies. The sequence is of high interest due to its selective expression in melanoma cells and its ability to elicit immune responses, making it a valuable molecular tool for dissecting tumor immunogenicity and antigen-specific cellular interactions. Its defined structure and immunological relevance provide a robust platform for the investigation of peptide-based recognition mechanisms and the development of targeted research applications in cancer biology.
Immunological Assays: The peptide is widely utilized in immunological assays aimed at characterizing antigen-specific T-cell responses. Its defined epitope sequence enables researchers to evaluate the activation, specificity, and cytotoxic potential of T lymphocytes against melanoma-associated antigens. By incorporating this peptide into ex vivo or in vitro systems, investigators can quantitatively and qualitatively assess T-cell recognition, cytokine production, and proliferation in response to melanoma antigens, thereby advancing the understanding of tumor immune surveillance and epitope presentation.
Peptide-MHC Binding Studies: The fragment serves as an essential reagent for investigating peptide-MHC (major histocompatibility complex) binding dynamics. Researchers employ it to evaluate the affinity and stability of peptide-MHC complexes, which are critical for effective antigen presentation and T-cell activation. Such studies facilitate the identification of key anchor residues, elucidate the molecular basis of immune recognition, and support the rational design of more potent peptide epitopes for immunological research.
Antigen Processing Research: As a model substrate, the peptide is instrumental in studies exploring the mechanisms of antigen processing and presentation within the cellular context. By tracking its intracellular fate, researchers can dissect proteasomal degradation pathways, peptide transport, and loading onto MHC molecules. Insights gained from these experiments contribute to a deeper understanding of how tumor-associated antigens are generated and displayed, informing the development of more effective antigenic peptides for downstream applications.
Peptide-Based Immunomonitoring: The defined sequence of this peptide enables its use in immunomonitoring protocols, particularly for tracking antigen-specific T-cell populations in research samples. Its application in flow cytometry, ELISPOT, and tetramer staining assays allows for precise quantification and characterization of immune responses in experimental models. This capability is critical for evaluating the efficacy of immunomodulatory interventions and for mapping the immune landscape in tumor-bearing systems.
Epitope Mapping and Vaccine Design Research: The peptide provides a valuable template for epitope mapping studies, facilitating the identification of minimal T-cell epitopes and the determination of sequence motifs essential for immune recognition. These investigations support the rational design of next-generation peptide-based vaccines and immunotherapeutic agents by pinpointing regions of the antigen that are most effective at stimulating immune responses. The use of this fragment in such research underscores its significance as a tool for advancing peptide engineering and targeted immunological investigations.
3. Cationic cell-penetrating peptides are potent furin inhibitors
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More